Studies Suggest Testosterone Therapy Poses No CV Risk in Men
New data from two studies indicate that testosterone therapy is not associated with cardiovascular risks, which challenges recent FDA decisions.
New data from two studies indicate that testosterone therapy is not associated with cardiovascular risks, which challenges recent FDA decisions.
Nearly half of patients with prediabetes enrolled in a comprehensive health program plus usual care had normal blood glucose by 6 months.
Patients with hypertension, obesity or diabetes at age 45 years were diagnosed with heart failure more than a decade earlier than those without these risk factors.